Search results
This Clinical Management Guideline outlines the aetiology, signs and symptoms and evidence-based recommendations for diagnosing periocular BCC. It highlights the need for referral for surgical excision and provides recommendations on the collection of clinical details and history to aid assessment of urgency.
10 sty 2018 · Despite advances in topical and systemic therapies, as well as a variety of energy devices, surgery remains the cornerstone of BCC treatment. Three surgical treatment modalities are reviewed in this section: standard excision, MMS, and C&E. Nonsurgical therapies, including radiotherapy and cryosurgery, are addressed separately.
In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC.
18 cze 2019 · Histopathological confirmation is mandatory in ambiguous lesions and in BCCs located in high-risk areas. The first-line treatment of ‘easy-to-treat’ BCC is complete surgery. Microscopically controlled surgery shall be offered for high-risk BCC, recurrent BCC and BCC in critical anatomical sites.
Vismodegib (Erivedge TM) has been approved in 2013 by Health Canada for adult patients with “histologically confirmed metastatic BCC or locally advanced BCC inappropriate for surgery or radiation.” An expert consensus was sought to create a standardised approach in the use of this novel treatment.
28 cze 2008 · There are several effective modalities available to treat basal cell carcinoma (BCC). 1,2 Guidelines aim to aid selection of the most appropriate treatment for individual patients. Careful assessment of both the individual patient and certain tumour-specific factors are key to this process. Definition.
13 lip 2023 · The present guidelines contain recommendations regarding diagnosis, therapy, and follow-up of patients with BCC, addressing in detail all aspects of BCC management, from the common types of tumours to those which are ‘difficult-to-treat’ or ‘advanced.’
